[Evaluation of therapeutic value of hydroxycarbamid "Polfa" (hydroxyurea) in rheumatoid arthritis].
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004341:Drug Evaluation; D004345:Drug Industry; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011044:Poland
D006918:Hydroxyurea
Ocena wartości leczniczej preparatu hydroxycarbamid "Polfa" (hydroksymocznik) w reumatoidalnym zapaleniu stawów.